Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals.

April 26 - 27, 2013

New York, New York
The Westin NY Times Square

Dear Colleague,

It is with great pleasure and enthusiasm that we invite you to join us in New York, April 26 - 27, 2013 for Great Debates & Updates in Hematologic Malignancies! Interactive and educational, this conference will focus on controversial areas in the management of hematologic malignancies as nationally-recognized thought leaders take opposing sides on topics of clinical interest.

Covering the broad continuum of hematologic malignancies, from lymphoma to leukemia to myeloma to myeloproliferative disorders, this one-of-a-kind hematology conference has a broad appeal to attendees and provides a substantial curriculum. The unique format will include didactic presentations, in conjunction with lively and interactive debates, covering some of the most controversial topics in the field.

Faculty and audience discussion will be encouraged with a focus on how new information fits into current community practice, as attendees will have the chance to really engage themselves with an insightful look at more than one side of a question. Discussions will focus on how the new data fits into current community practice of hematology, and will be aimed at facilitating rapid incorporation of important new advances in treatment into your current practice.

For any healthcare professional interested and/or involved in the management and treatment of patients with hematologic malignancies, this conference is one that you will not want to miss!

We look forward to seeing you in New York this Spring for what promises to be a rewarding professional update!


John P. Leonard, MD
Robert Z. Orlowski, MD, PhD
David P. Steensma, MD

Important Dates

Early Registration Deadline

April 14, 2013

Discounted Registration Deadline

April 18, 2013

Presentation Dates

April 26 – 27, 2013

Bring your laptop, tablet, or smart phone

In a continuing effort to be environmentally conscious, all slide presentations, pending speaker approval, will be available to view on the electronic device of your choice—laptop, tablet, smart phone, etc., via ARRAY technology. A printed summary book will not be available and we encourage you to bring your electronic device to the conference for optimal participation.

This technology is the most convenient way to provide attendees with the most up-to-date information. After the conference, a link to download the presentations will be emailed to attendees.



The Lymphoma Research Foundation(LRF) is the nation's largest non-profit organization devoted exclusively to funding innovative lymphoma research and providing people with lymphoma and healthcare professionals with up-to-date information about this type of cancer. LRF's mission is to eradicate lymphoma and serve those touched by this disease. LRF’s goal is to change the future for everyone whose life has been affected by a lymphoma diagnosis. LRF is dedicated to funding biomedical research focused on the origins, treatment and identification of a cure for lymphoma; to raising public awareness of the disease; and providing support and services to people with lymphoma, their families and caregivers.


11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334

For registration inquiries:
Tel.: +1 (678) 242-0906 
Toll-free (USA only): +1 (800) 233-0957 
Fax: +1 (770) 751-7334